Healthcare Equipment and Supplies
Company Overview of Semprus BioSciences Corp.
Semprus BioSciences Corp. provides complication-free medical devices. The company’s Semprus Sustain technology is a permanent non-leaching biomaterial modification to the device surface that prevents medical complications, such as infection, blood clots, improper healing, and cell overgrowth. It focuses on enabling permanently dual-functional (anti-colonization and anti-thrombogenic) vascular access catheters with a single surface modification. It also focuses on developing new products to reduce microbial adhesion, deliver drugs, bind with agents in the bloodstream, or provide improved accuracy for diagnostics. It was formerly known as SteriCoat Corp. and changed its name to Semprus BioScie...
One Kendall Square
Building 1400 West
Cambridge, MA 02139
Founded in 2006
Key Executives for Semprus BioSciences Corp.
Co-Founder and Chief Technology Officer
Co-Founder, Chairman of Scientific Advisory Board, and Director
Compensation as of Fiscal Year 2015.
Semprus BioSciences Corp. Key Developments
Semprus BioSciences Corp. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 11:00 AM
Mar 14 14
Semprus BioSciences Corp. Presents at Boston Biotech BD Boston Conference, Mar-25-2014 11:00 AM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: David L. Lucchino, Co-Founder, Chief Executive Officer and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries